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http://dx.doi.org/10.1016/j.stemcr.2016.08.014SUMMARYMitochondria are critical to neurogenesis, but the mechanisms of mitochondria in neurogenesis have not been well explored. We fully
characterized mitochondrial alterations and function in relation to the development of human induced pluripotent stem cell (hiPSC)-
derived dopaminergic (DA) neurons. Following directed differentiation of hiPSCs to DA neurons, mitochondria in these neurons exhibit
pronounced changes during differentiation, includingmature neurophysiology characterization and functional synaptic network forma-
tion. Inhibition of mitochondrial respiratory chains via application of complex IV inhibitor KCN (potassium cyanide) or complex I
inhibitor rotenone restricted neurogenesis of DA neurons. These results demonstrated the direct importance of mitochondrial
development and bioenergetics in DA neuronal differentiation. Our study also provides a neurophysiologic model of mitochondrial
involvement in neurogenesis, which will enhance our understanding of the role of mitochondrial dysfunctions in neurodegenerative
diseases.INTRODUCTION
Human induced pluripotent stem cells (hiPSCs) are remark-
able for their ability to self-renew and differentiate into
various tissues and cell types (Takahashi and Yamanaka,
2006). Differentiation of these cells into a specific cell
type allows for in-depth study with the goal of cell replace-
ment therapy for neurodegenerative diseases such as Par-
kinson’s disease (PD), which is caused by selective loss of
dopaminergic (DA) neurons in the substantia nigra pars
compacta in the midbrain (Xu et al., 2013b). Expanding
our knowledge of the cellular and molecular factors
involved in the maturation and differentiation of human-
derived neurons will significantly boost our ability to
manipulate and generate specific cell types for disease
therapy.
Mitochondria are highly dynamic organelles with com-
plex structures involved in multiple processes, including
energy metabolism, reactive oxygen species (ROS) genera-
tion, mitochondrial dynamics and distribution, and the
induction of apoptosis. A number of recent studies have
highlighted the key role of mitochondrial biogenesis in
stem cell differentiation (Prigione et al., 2011; Teslaa and
Teitell, 2015; Xu et al., 2013a). Upregulation of mitochon-
drial mass andmtDNA and increased oxygen consumption
levels were observed during differentiation of embryonic
stem cells (ESCs) (Prigione et al., 2011). In addition, mito-
chondria gained structural maturity, displaying larger
morphology during differentiation (Bukowiecki et al.,
2014). This morphologic change was accompanied by a
metabolic transition from glycolysis to mitochondrial678 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016 j ª 2016
This is an open access article under the CC BY-NC-ND license (http://creativrespiration in both cardiac andmotor-neuronal directional
differentiation (O’Brien et al., 2015). Inhibition of mito-
chondrial respiration leads to the impairment of differenti-
ation ability and enhancement of stem cell pluripotency
(Varum et al., 2009). Thus, the development of a mature
mitochondrial network in terms of mitochondrial func-
tion and structure is necessary during the differentiation
of PSCs.
Mitochondrial dysfunction occurs in a wide variety of
degenerative diseases such as aging, cancer, and neurode-
generative diseases (Mattson et al., 2008; Perier and Vila,
2012). Mitochondrial ROS (mROS) levels are tightly regu-
lated and linked to a wide range of physiologic processes
(Genova et al., 2004). mROS are also involved in cellular
processes that are critical for maintenance of homeostasis
and adaptation to stress (Chandel et al., 1998). Recent
studies showed that human ESCs maintain their genomic
integrity by limiting the accumulation of ROS (Armstrong
et al., 2010; Asensi et al., 2014), However, overproduction
of mROS has adverse effects on cellular function including
that of PSCs (Genova et al., 2004; Sena and Chandel, 2012;
Tapia, 2006; Wu et al., 2013). In hiPSC-induced neurons
derived from PD patients, mitochondrial dysfunction and
high levels of ROS result in increased vulnerability of these
cells (Cooper et al., 2012). Mechanisms underlying mito-
chondrial defects in hiPSC-derived tyrosine hydroxylase
(TH)-positive DA neurons are not well understood.
To better understand the role of mitochondria in the
development and differentiation process of hiPSCs into
DA neurons, we evaluated changes in mitochondrial dy-
namics and function in DA neurons during various phasesecommons.org/licenses/by-nc-nd/4.0/).
of differentiation.We fully characterized and evaluated the
neurophysiology, morphology, and neuronal and synaptic
markers to monitor maturation and synaptic activity in
hiPSC-derived DA neurons. Importantly, interruption of
mitochondrial respiration by inhibiting complex IV or I
activity significantly obstructed the differentiation of
DA neurons. Our current study clearly demonstrated the
importance of mitochondria in DA neuronal differentia-
tion and maturation. We therefore provide a dynamic
model for further investigation of the involvement ofmito-
chondrial dysfunction in the development of neurodegen-
erative diseases.RESULTS
hiPSC Characterization and DA Neuron-Directed
Differentiation
We first assessed pluripotency in bone marrow 2-3 (BM2-3)
hiPSCs. These cells were immunoreactive for pluripotency
markers NANOG, OCT4, SSEA3, and SOX2 (Figure S1A).
Our iPSCs were successfully kept in an undifferentiated
state for more than 20 passages. The cells formed uni-
form-sized embryoid bodies (EBs) 24 hr after being plated
into AggreWell800 plates (Figure S1B). One to two days af-
ter attachment of EBs, prominent neural rosette structures
appeared in neural aggregates with the addition of Rock in-
hibitor (Y27632). About 98% of attached neural aggregates
had polarized rosettes covering >50% of their area. Rosettes
were formed by cells expressing proteins characteristic
of progenitor markers of PAX6 (green) and Ki-67 (red)
(Figure S1C, and immunoblot results in Figure S1D).
Dachshund family transcription factor 1 (DACH1) and
promyelocytic leukemia zinc finger expressions from our
semi-quantitative PCR results confirmed the neural rosette
characteristics (Figure S1E). Endogenous pluripotency
markerOCT4 andprogenitormarker PAX6were downregu-
lated in differentiated neurons kept in the DA neuronal
differentiation medium for 10, 15, and 20 days, whereas
expression levels of mature neuron-specific marker TUJ1
(neuron-specific class III b-tubulin) and DA neuron marker
TH were significantly increased during these same periods
of time (Figures 1A–1E).
Real-time qPCR results showed that the mRNA for earlier
markers expressed in midbrain dopaminergic neuron pro-
genitors or immature dopaminergic neurons, including
LIM-homeobox transcription factor 1 alpha, LMX1A, and
Engrailed 1 (EN1); a basal and floorplate marker (Forkhead
Box A2, FOXA2) (Nakatani et al., 2010), and a transcription
factor, expressed at the rostral to midbrain/hindbrain
boundary, Orthodenticle Homeobox 2 (OTX2) (Millet et al.,
1996). These reached a plateau at the stage of neural pro-
genitor cells (NPCs) (Figure 1F).In contrast, the mRNA levels of dopamine transporter
(DAT), aromatic L-amino acid decarboxylase (AADC), and
vesicular monoamine transporter 2 (VMAT2), markers of
mature DA neurons (Bjorklund et al., 2002; Kim et al.,
2011), and the marker for mature neurons, microtubule-
associated protein 2 (MAP2), are increased over time during
dopaminergic neuron induction (Figure 1F).
We observed significant growth of dendrites with the
longest processes noted on day 20 as measured by TUJ1-
or TH-positive process length during the course of differen-
tiation (Figures 1G and 1H). These data indicate that DA
neurons can be induced to display mature neuronal
characteristics in our differentiation system directed at
DA neurons.
Physiological Characteristics of Differentiated DA
Neurons
To further determine whether DA neurons derived from
differentiated hiPSCs actually have a neurophysiologic
function, we next examined the electrophysiologic prop-
erties of hiPSC-induced DA neurons. During differentia-
tion, the ability to fire bursts of action potentials in
response to current injection increased over time (Figures
2A and 2B). None of the neurons exhibited action poten-
tials until day 10 of the incubation in DA differential
media when a single potential appeared (Figure 2B). The
frequency continued to increase up to day 20 (Figures
2A and 2B). Electrophysiological parameters such as
resting membrane potential and action potential genera-
tion showed signs of membrane maturation over time
(Figures 2A and 2B). Four cells (1.7%, n = 242) showed
spontaneous action potentials, some appearing as early
as 15 days after induction (Figure 2C). We were able to
block the action potentials with the addition of tetrodo-
toxin (TTX), a specific inhibitor of Na+ ion channels (Fig-
ure 2D, upper panel).
Whole-cell patch-clamp recordings from individual cells
revealed the presence of voltage-gated sodium currents and
voltage-gated potassium currents in hiPSC-derivedDAneu-
rons; these increased over the timeof induction (Figure 2C).
In voltage-clamp mode, we observed fast inactivating in-
ward and outward currents, which probably correspond
to the opening of voltage-dependent Na+ and K+ channels,
respectively. The fast inward currents were reversibly
blocked with the addition of TTX (Figure 2D, upper panel)
and the outward currents were reversibly blocked by tetrae-
thylammonium, an inhibitor of voltage-dependent K+
channels (Figure 2D, lower panel). Na+ and K+ channels
also showed signs of maturation over time of induction
(Figures 2C–2E). Taken together, these data demonstrate
that hiPSC-derived DA neurons are functional after
15 days of differentiation in our DA neuron induction






Figure 1. Differentiation and Development of hiPSC Line-Induced Human DA Neurons
(A–E) Expression of pluripotency marker (OCT4), precursor cells marker (PAX6), neuron-specific marker (neuron-specific class III
b-tubulin, TUJ1), and midbrain dopaminergic neuronal marker (TH) in neuronal populations in differentiation media for 10, 15, and
20 days. (A–D) Densitometry of the combined immunoreactive bands for OCT4 (A), PAX6 (B), TUJ1 (C), and TH (D) normalized to b-actin
using NIH ImageJ software. Data are expressed as fold increase relative to DA neurons cultured in differentiation media for 10 days (n = 3
independent experiments; mean ± SEM). (E) Representative immunoblots for OCT4, PAX6, TUJ1, TH, and b-actin. b-Actin was used as a
protein loading control.
(F) Real-time qPCR results for gene expression. The expression level of the undifferentiated hiPSC cells was set to 1 (n = 3 independent
experiments).
(G and H) Co-expression of TUJ1 and TH in hiPSC-induced neurons cultured in differentiation media for 5, 10, 15, and 20 days. Quan-
tification of neuronal process length of TUJ1-positive neurons and TH-positive DA neurons in differentiation media for different days was
performed using NIH ImageJ (G). #p < 0.01 compared with day-5 (5d) cells, length of TUJ1 positive dendrites, and *p < 0.01 compared with
5d cells, length of TH positive dendrites (n = 3 independent experiments; mean ± SEM, with 10 cells quantified per experiment). (H)
Representative images for immunostaining of TUJ1 (green), TH (red), and co-localization (merge, yellow). Scale bars, 50 mm.
For (A), (D), and (G), statistical analysis was performed using StatView software version 5.0.1 (SAS Institute). One-way ANOVA was used for
repeated-measures analysis, followed by Fisher’s protected least significant difference for post hoc comparisons. Data are presented as
mean ± SEM. Three independent experiments in (A–H); n = 10 cells per group per experiment in (G).Formation of Functional Excitatory Synapses in hiPSC
Differentiated DA Neurons
Synaptogenesis is a critical indicator of neural network for-
mation. Using immunocytochemistry, we demonstrated
that the number of synaptophysin (SYN)-positive puncta
was significantly increased in day-15 to day-20 DA neurons680 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016compared with day-10 DA neurons (Figures 2F and 2G).
There was an abundance of pre-synaptic compartments
(SYN-positive puncta) localized along the dendrites of
TH-positive DA neurons that were differentiated for a
period of 20 days (Figure 2F), whereas SYN-positive puncta
were barely detectable in the DA neurons that were
(legend on next page)
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differentiated for 10 days. Consistent with the immuno-
staining results, SYN protein expression levels were
elevated over the time of induction (Figure 2H).
We next performed a whole-cell patch-clamp recording
to detect spontaneous postsynaptic currents (sPSCs)
in the day-20 neurons to assess their neuronal func-
tion. As shown in Figure 2I, sPSCs with 10- to 60-pA
amplitudes occurred frequently. Fourteen cells (5.8%,
n = 242) exhibited the presence of sPSCs, suggesting
that hiPSCs have the capacity to form functional synap-
ses. These data demonstrate that functional and
excitatory synapses are generated during the course of
differentiation.
Alteration of Mitochondrial Function in hiPSC
Differentiated DA Neurons
We next estimated mitochondrial potential and integrity
of iPSC-induced DA neurons by assessing their ability to
incorporate the mitochondrial membrane-permeable fluo-
rescent dye tetramethylrhodamine methyl ester (TMRM),
which is readily sequestered by active mitochondria. Mito-
chondrial membrane potential was significantly increased
1.6-, 2.3-, and 2.6-fold in day-10, -15, and -20 DA neurons,
respectively (Figures 3A and 3B).
Given the important role of mitochondria in neuronal
transmission and function, we next evaluated mitochon-
drial respiratory function and energy metabolism. We
measured enzymatic activity for complexes I and IV, key
enzymes associated with the respiratory chain, and ATPFigure 2. Electrophysiologic Characterization of Maturation of hi
(A) Quantification of resting membrane potential in hiPSC-derived DA
Numbers in the bars represent the numbers of recorded cells (n = 3 in
(B) Representative traces of membrane potential responding to step d
20-pA increments. Membrane potential was current-clamped at the re
(C) Quantification of Na+ and K+ currents recorded from DA neurons at i
with 13–16 cells per group in Na+ currents record, 15 cells per group
(D) Representative traces of Na+ currents (upper panel) and K+ curren
step depolarization from70 mV to +50 mV at 10-mV increments were
DA neurons were blocked by 0.5 mM tetrodotoxin (TTX) and 10 mM
following TTX or TEA washout.
(E) TTX-sensitive spontaneous action potentials recorded from a DA ne
(F) Immunocytochemistry of synaptophysin (SYN, marker for synapti
(G) Quantification of numbers of SYN-positive clusters along the branc
differentiation media for 10, 15, and 20 days (n = 3 independent exp
(H) Analysis of western blots for Syn protein expression. Quantificat
normalized to the expression level of internal control b-actin (n = 3 i
shown for SYN and b-actin in the lower panel.
(I) Representative spontaneous postsynaptic currents (sPSCs) recorde
for 20 days.
Statistical analysis was performed using StatView version 5.0.1. For (
analysis, followed by Fisher’s protected least significant difference fo
independent experiments in (A), (C), (G), and (H); n = 32–37 cells per g
and n = 15 cells per group in K+ currents record. In (G), n = 4 cells p
682 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016levels in hiPSC-derived DA neurons. Complex I and IV ac-
tivity was significantly increased on day 20, compared
with day-10 and -15 differentiated neurons (Figures 3C
and 3D). Similarly, ATP levels were significantly elevated
on day 15–20 compared with those from day 10 (Fig-
ure 3E). These results suggest enhanced mitochondrial
respiratory chain function and energy metabolism
during the course of maturation of hiPSC-DA neurons,
which could result in increased mitochondrial membrane
potential.
Overproduction of mitochondria-produced ROS is
damaging to the cell, thereby accelerating pathologies
and aging (Cooper et al., 2012). Recent work has revealed
that mitochondrial ROS are integral signaling molecules
that promote proliferation, and possibly also control differ-
entiation (Chandel et al., 1998; Sena and Chandel, 2012;
Tapia, 2006). We therefore assessed mitochondrial ROS
levels by evaluating MitoSOX staining intensity in the
neuronal terminals upon differentiation. The intensity of
MitoSOX signals was increased in day-10, -15, and -20
differentiated DA neurons (Figures 3F and 3G). To further
confirm the increased ROS levels during differentiation,
we quantitatively measured the intracellular ROS levels
by highly specific election paramagnetic resonance (EPR)
spectroscopy. Compared with day 5 of differentiated DA
neurons, the intracellular ROS levels were elevated at
days 10, 15, and 20 of differentiated DA neurons (Figures
3H and 3I). Both mitochondrial ROS levels and mitochon-
drial function were highest on day 20 of differentiation.PSC-Derived DA Neurons
neurons cultured in differentiation media for 10, 15, and 20 days.
dependent experiments; mean ± SEM).
epolarization by current injections ranging from10 pA to 90 pA at
sting membrane potential.
ndicated days after differentiation. (n = 3 independent experiments
in K+ currents record; mean ± SEM).
ts (lower panel) in voltage-clamp mode; cells were held at 70 mV;
delivered (lower panel). Na+ currents and K+ currents recorded from
tetraethylammonium (TEA), respectively. Both currents recovered
uron 20 days after differentiation. No current injection was applied.
c terminals, green) and TH (red). Scale bars, 20 mm.
hes of hiPSC-derived DA neurons (TH-positive dendrites) cultured in
eriments; mean ± SEM, with 4 cells quantified per experiment).
ion of SYN expression level is shown in the upper panel. Data are
ndependent experiments; mean ± SEM). Representative images are
d from hiPSC-derived DA neurons cultured in differentiation media
A), (G), and (H), one-way ANOVA was used for repeated-measures
r post hoc comparisons. Data are presented as mean ± SEM. Three
roup in (A). In (C), n = 13–16 cells per group in Na+ currents record,
er group per experiment.
Figure 3. Development of Mitochondrial Functions in hiPSC-Derived DA Neurons
(A–G) Mitochondrial membrane potential and ROS levels were measured by TMRM (A and B). Representative images for TMRM staining for
hiPSC-derived DA neurons cultured in differentiation media for 5, 10, 15, and 20 days are shown in (A), and quantifications of immu-
nofluorescent intensity for TMRM in (B) (n = 3 independent experiments; mean ± SEM, with 5 cells quantified per experiment). Enzymatic
activity of complex I (C), IV (D), and cellular ATP levels (E) were determined in cell lysates from hiPSC-derived DA neurons cultured in
differentiation media for 10, 15, and 20 days (n = 3 independent experiments; mean ± SEM in C–E). Mitochondrial ROS levels were
(legend continued on next page)
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These data suggest that upregulation of ROS production
may be important for maintaining mitochondrial homeo-
stasis, contributing to DA neuron differentiation and
maturation.
Alterations in Mitochondrial Morphology and
Mobility in hiPSC Differentiated DA Neurons
Next, we compared mitochondrial morphology and
mobility in the processes of hiPSC differentiated toDAneu-
rons. Using MitoGreen staining (Figures 3A and 3F) as a
mitochondrial marker, we observed that mitochondria in
day-5 and day-10 DA neurons were mostly short in length
and dot shaped, whereas mitochondria became longer on
later differential days. Increased densities of both short
and longmitochondria were detected as the differentiation
process continued. Compared with day-5 neurons, mito-
chondrial density increased by 1.4- and 2.0-fold in each
process (100 mm in length) in DA neurons differentiated
for 15 and 20 days, respectively (Figure 4A). The number
of mitochondria in all processes of each neuron was
increased by 2.2- and 5.9-fold on days 15 and 20, respec-
tively (Figure 4B). The average length of mitochondria
was 2.1 mm, 3.2 mm, and 3.8 mm on days 10, 15, and 20,
respectively (Figure 4C). Most mitochondria were shorter
than 2 mmor ranged from 2 to 4 mmon day 10. In contrast,
day-15 and day-20 mitochondria were longer than 4 mmor
ranged from 2 to 4 mm. Fewer than 3%of day-20mitochon-
dria were shorter than 2 mm (Figure 4D). Cumulative distri-
bution data clearly demonstrated accumulated percentile
of long mitochondria over time under differentiation in-
duction (Figure 4E).
We further investigated dynamic indicators of mito-
chondria movement. Compared with the mitochondria
from the day-10 differentiated DA neurons (Movie S1A),
mitochondria were elongated and displayed higher
movement speed with significantly longer travel distance
in neuronal processes of hiPSC-derived DA neurons
differentiated for 15 (Movie S1B) and 20 days (Movie
S1C). Mitochondrial travel distance (Figure 4F), velocity
(Figure 4G), and the percentage of anterograde and
retrograde movable mitochondria (Figures 4H and 4I)
increased, while the percentage of stationary mitochon-measured by MitoSOX staining (F and G). Representative images for
entiation media for 5, 10, 15, and 20 days are shown in (F). Quantifi
(n = 3 independent experiments; mean ± SEM, with five cells quantifi
(H and I) EPR for measurement of intracellular ROS levels. Represent
entiation media for 5, 10, 15, and 20 days are shown in (H), and qu
mean ± SEM).
Data are expressed as fold increase relative to DA neurons cultured in d
using StatView version 5.0.1. For (B–E), (G), and (I), one-way ANO
protected least significant difference for post hoc comparisons. Data
(A–I); n = 5 per group per experiment in (B) and (G). Scale bars in (A
684 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016dria decreased over the time course of differentiation
and maturation (Figure 4H). Representative kymograph
images (Figure 4J) showed more movable mitochondria
in the processes of the day-15 and -20 differentiated DA
neurons. Collectively, our results demonstrate increased
dynamics in mitochondria of hiPSC-derived DA neurons
during differentiation.
Effect of Mitochondrial Function on DA Neuron-
Directed Differentiation
To investigate the effect of mitochondrial respiratory func-
tion on DA neuron differentiation, we blocked key enzyme
activity in the respiratory chain by incubation of potassium
cyanide (KCN), a complex IV inhibitor (500 nM), and rote-
none, a complex I inhibitor (10 nM)with cells, respectively,
and then analyzed the differentiation ability of DA neu-
rons. As shown in Figure 5A, the inhibitors/toxins formito-
chondrial respiratory chains were added 2 days after the
rosettes were plated. Earlier applications of the inhibitors
to the stage of undifferentiated hiPCS (Figure S2A) resulted
in significantly smaller-sized EBs (Figures S2B and S2C), dis-
abilities in rosette formation (Figures S2D–S2G), and signif-
icant reduction in complex IV and I activities (Figures S2H
and S2I), and ATP levels (Figure S2J).
We next measured the TUJ1- or TH-positive process
length in day-20 differentiated neurons. Both indicators
were markedly decreased with KCN and rotenone treat-
ments (Figures 5B and 5C). Similarly, the number of SYN-
positive puncta (Figures 5D and 5E) and its protein levels
were significantly reduced in day-20 DA neurons with the
treatment of mitochondrial inhibitors (Figure 5F). These
data indicate that mitochondrial dysfunction inhibits DA
neuron maturation and synaptogenesis in our differentia-
tion system.
To further validate the midbrain dopaminergic neurons,
we quantified levels of earlier markers for DA neuronal
maturation by real-time PCR. In comparison with
vehicle-treated mitochondria, not only were the levels of
earlier markers, such as EN1, FOXA2, LMX1A, and OTX2,
significantly lower in DA neurons under KCN and rote-
none treatments (Figures 5G–5J), but also their decreasing
rates were relatively slow over the induction time.MitoSOX staining for hiPSC-derived DA neurons cultured in differ-
cation of immunofluorescent intensity for MitoSOX is shown in (G)
ed per experiment).
ative EPR images for hiPSC-derived DA neurons cultured in differ-
antification of EPR signals in (I) (n = 3 independent experiments;
ifferentiation media for 10 days. Statistical analysis was performed
VA was used for repeated-measures analysis, followed by Fisher’s
are presented as mean ± SEM. Three independent experiments in
) and (F) represent 5 mm.
A B C D
E F G
H I J
Figure 4. Development of Mitochondrial Morphological and Dynamic Parameters in hiPSC-Derived DA Neurons
(A–D) Morphological changes in mitochondria of hiPSC-derived DA neurons cultured in differentiation media for 10, 15, and 20 days were
measured and compared. Average mitochondrial density (in each 100-mm process in A and in all processes of each DA neuron in B), length
(C), and frequency (D) in the processes of DA neurons were quantified.
(E) Cumulative distribution data showed increases in the numbers of long mitochondria and decreases in fragmentation of small mito-
chondria at 10, 15, and 20 days after differentiation induction (n = 3 independent experiments; mean ± SEM, with 10 mitochondria
quantified per experiment in A–E).
(F–I) Average mitochondrial travel distance (F) and mitochondrial travel velocity (G) were calculated. The percentage of stationary (H),
anterograde, and retrograde movable mitochondria (I) in DA neurons differentiated for varying days was compared. (n = 3 independent
experiments; mean ± SEM, with 10 mitochondrial movements quantified per experiment in F–I).
(J) Kymographs generated from live imaging movies represent hiPSC-derived DA neurons cultured in differentiation media for 10, 15, and
20 days. In the kymographs, the x axis is mitochondrial position and the y axis represents the time lapse of 0–120 s. Vertical white lines
represent stationary mitochondria and diagonal lines represent moving mitochondria. Anterograde movements are from left to right and
retrograde movements are from right to left.
*p < 0.05 versus day-10 movable mitochondria and #p < 0.05 versus day-10 stationary mitochondria in (H). Scale bar, 10 mm in (J).
Statistical analysis was performed using StatView version 5.0.1. For (A–D) and (F–I), one-way ANOVA was used for repeated-measures
analysis, followed by Fisher’s protected least significant difference for post hoc comparisons. Data are presented as mean ± SEM. Three
independent experiments in (A–I); n = 10 per group per experiment in (A–I).Similarly, the expression levels for mature DA neurons
including AADC, DAT, VMAT2, and mature neurons,
MAP2, were completely blocked in the presence of KCNand rotenone (Figures 5K–5N). These results demonstrate
a direct link between mitochondrial alteration and DA














Figure 5. Effect of Mitochondrial Inhibitor KCN or Rotenone on Differentiation of hiPSC Line-Induced Human DA Neurons
(A) Schematic representation of differentiation of hiPSC line-induced DA neurons under KCN or rotenone treatment.
(B and C) Co-expression of TUJ1 and TH in hiPSC-induced neurons cultured in differentiation media for 20 days under KCN or rotenone
treatment. (B) Representative images for immunostaining of TUJ1 (green) and TH (red). Scale bars, 50 mm. (C) Quantification of neuronal
process length of TUJ1-positive neurons and TH-positive DA neurons in differentiation media for different days was performed using NIH
ImageJ. #p < 0.01 compared with vehicle (day-20) cells, length of TUJ1 positive dendrites, and *p < 0.01 compared with vehicle (day-20)
cells, length of TH positive dendrites (n = 3 independent experiments; mean ± SEM, with 10 cells quantified per experiment).
(D) Immunocytochemistry of SYN (green) and TH (red). Scale bars, 50 mm.
(E) Quantification of numbers of SYN-positive clusters along the branches of hiPSC-derived DA neurons cultured in differentiation media
for 20 days with or without KCN or rotenone treatment (n = 3 independent experiments; mean ± SEM, with 10 cells quantified per
experiment).
(F) Immunoblotting for SYN protein expression. Quantification of SYN expression level is shown in the upper panel. Data are normalized to
the expression level of internal control b-actin. Representative images are shown for SYN and b-actin in the lower panel (n = 3 independent
experiments; mean ± SEM).
(G–N) Real-time qPCR results for gene expression. The expression level of the undifferentiated hiPSC cells was set to 1 (n = 3 independent
experiments; mean ± SEM).
Statistical analysis was performed using StatView version 5.0.1. For (C), (E), and (F), one-way ANOVA was used for repeated-measures
analysis, followed by Fisher’s protected least significant difference for post hoc comparisons. Data are presented as mean ± SEM. Three
independent experiments in (B–N); n = 10 per group per experiment in (C) and (E).Effect of Mitochondrial Function on the Development
of Mitochondrial Functions, Morphology, and
Mobility in hiPSC-Derived DA Neurons
We then assessed the effects ofmitochondrial inhibitors on
mitochondrial membrane potential and ROS levels. TMRM686 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016staining, an indicator formembrane potential, was reduced
by66% (Figures 6A and 6B).Mitochondrial superoxide, as
shown byMitoSOX staining, was increased by2.2-fold in
KCN and rotenone-treated day-20 DA neurons, respec-
tively (Figures 6C and 6D), which was consistent with the
(legend on next page)
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EPR results showing a significant increase in ROS levels in
cells treated with KCN or rotenone (Figures 6E and 6F).
Accordingly, treatment of KCN or rotenone suppressed
the activity of complex IV (Figure 6G) and I (Figure 6H),
and ATP levels (Figure 6I) in day-20 neurons. To determine
the effect of mitochondrial inhibitor/toxins on mitochon-
dria morphological changes in day-20 DA neurons, we
stained cells with MitoGreen to visualize mitochondrial
morphology (Figures 6A and 6C). Compared with
vehicle-treated day-20 DA neurons, KCN or rotenone treat-
ment resulted in a decrease in mitochondrial density and
length with mostly shorter and dot-shaped mitochondria
(Figures 6J–6L). The percentage of short mitochondria
was significantly elevated over time under KCN and rote-
none treatments (Figure 6M).
We further investigated dynamic changes in mitochon-
dria movement. Compared with the mitochondria from
the day-20 differentiated DA neurons treated with vehicle
(Movie S1D), mitochondria in neuronal processes of DA
neurons with KCN (Movie S1E) and rotenone treatments
(Movie S1F) displayed less movable and more stationary
mitochondria. Similarly, treatment with KCN or rotenone
significantly reduced mitochondrial travel distance
(Figure 6N), velocity (Figure 6O), and the percentage of
anterograde and retrogrademovablemitochondria (Figures
6P and 6Q). Conversely, the percentage of stationary mito-Figure 6. Effect of Mitochondrial Toxin KCN or Rotenone on Develo
Parameters in hiPSC-Derived DA Neurons
(A–D) Mitochondrial membrane potential and ROS levels were measure
Representative images for TMRM and MitoSOX staining for hiPSC-deriv
without KCN or rotenone treatment are shown in (A) and (C), and qu
independent experiments; mean ± SEM, with five cells quantified per
(E and F) Assessment of intracellular ROS levels measured by EPR s
quantifications in (F) (n = 3 independent experiments; mean ± SEM)
(G–I) Activities of complex IV (G) and I (H), and ATP levels (I) were d
media for 20 days with above treatments. Data are expressed as fold
media for 20 days (n = 3 independent experiments; mean ± SEM).
(J–Q) Morphological changes in mitochondria of hiPSC-derived DA ne
KCN or rotenone treatment. Average mitochondrial density (J), len
quantified. (M) Cumulative distribution data showed decreases in the
small mitochondria with KCN or rotenone treatment (n = 3 independe
experiment in J–M). Average mitochondrial travel distance (N) and m
stationary (P), anterograde, and retrograde movable mitochondria (Q)
independent experiments; mean ± SEM, with 10 mitochondrial movem
(R) Kymographs generated from live imaging movies represent hiPSC-d
or without KCN or rotenone treatment. In the kymographs, the x axis i
0–120 s. Vertical white lines represent stationary mitochondria and
ments are from left to right and retrograde movements are from righ
*p < 0.05 versus vehicle (day-20) movable mitochondria and #p < 0.05
bar, 10 mm in (R). Statistical analysis was performed using StatView ve
used for repeated-measures analysis, followed by Fisher’s protected lea
Student’s t test was used for repeated-measures analysis. Data are pr
n = 5 cells per group per experiment in (B) and (D), and n = 10 mito
688 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016chondria was increased in cells treated with KCN or
rotenone (Figure 6P). Representative kymograph images
(Figure 6R) showed less movable mitochondria in the pro-
cesses of the day-20 differentiated DA neurons with KCN
and rotenone treatments. These data demonstrate that
aberrant mitochondrial function significantly reduces
mitochondrial dynamics in hiPSC-derived DA neurons.DISCUSSION
A recent study suggested that mitochondrial dysfunction
occurs in patient-derived hiPSC-induced human neurons
(Cooper et al., 2012), but detailed investigation of such
mitochondrial dysfunction in hiPSC-derived DA neurons
has yet to be undertaken. In this study, we comprehen-
sively monitored the differentiation, synaptogenesis, and
development ofmitochondrial functions of hiPSC-induced
human DA neurons by examining neurophysiology and
mitochondrial and synaptic function and structure. Our re-
sults obtained from neurophysiology reveal increases in
resting membrane potential, action potential, and conduc-
tance of voltage-gated Na+ channels and K+ channels in a
time-dependent manner in hiPSC-derived DA neurons un-
der our differentiation protocol. These data are indicative
of membrane maturation over time in differentiatingpment of Mitochondrial Functional, Morphological, and Dynamic
d by TMRM (A and B) and MitoSOX staining (C and D), respectively.
ed DA neurons cultured in differentiation media for 20 days with or
antifications of immunofluorescent intensity in (B) and (D) (n = 3
experiment in A–D). Scale bars, 5 mm.
pectroscopy. Representative images for EPR are shown in (E) and
.
etermined in hiPSC-derived DA neurons cultured in differentiation
increase relative to vehicle DA neurons cultured in differentiation
urons cultured in differentiation media for 20 days with or without
gth (K), and frequency (L) in the processes of DA neurons were
numbers of long mitochondria and increases in fragmentation of
nt experiments; mean ± SEM, with 10 mitochondria quantified per
itochondrial travel velocity (O) were calculated. The percentage of
in DA neurons differentiated for varying days was compared (n = 3
ents quantified per experiment in (N–Q).
erived DA neurons cultured in differentiation media for 20 days with
s mitochondrial position and the y axis represents the time lapse of
diagonal lines represent moving mitochondria. Anterograde move-
t to left.
versus vehicle (day-20) stationary mitochondria in (P and Q). Scale
rsion 5.0.1. For (B), (D), (F), (I–L), and (N–Q), one-way ANOVA was
st significant difference for post hoc comparisons. For (G) and (H),
esented as mean ± SEM. Three independent experiments in (A–R);
chondrial movements per group per experiment in (J–Q).
neuronal cells starting at day 15 after treatment with DA
differential media and peaking at day 20 in our present
study. Consistent with the alterations in neurophysiologic
properties, neuronal process length and expression levels
of both neuronal proteinmarkers, TUJ1 and TH (a dopami-
nergic neuronal marker), were altered in a similar pattern.
In addition, earlier markers, the transcription factors ex-
pressed in midbrain dopaminergic neuron progenitors or
immature dopaminergic neurons, including LMX1A (An-
dersson et al., 2006), EN1 (Simon et al., 2001), FOXA2
(Nakatani et al., 2010), and OTX2 (Millet et al., 1996), all
reached a plateau at the NPCs stage, while levels of markers
for mature DA neurons including DAT, AADC, and VMAT2
(Ang, 2006; Bjorklund et al., 2002; Kim et al., 2011), as well
as the marker for mature neurons,MAP2, all increased dur-
ing the course of dopaminergic neuron induction. These
results suggest, starting from the NPCs stage, continuous
maturation of hiPSC-derived DA neurons over time with
maximal adult values achieved by 20 days after induction
with DA neuronal media.
During development, neurons assemble to form culti-
vated neuronal networks. One of the critical indicators of
neural network formation is synaptogenesis (Colon-Ra-
mos, 2009). We observed increased synaptophysin expres-
sion levels and number of synaptophysin-positive puncta
over time. Moreover, we noted spontaneous postsynaptic
current generation starting at day 15 after treatment
with DA differential media, suggesting the capacity to
form functional synapses. Consistent with prior studies
of directed differentiation to functional neuronal networks
(Hartfield et al., 2014; Yang et al., 2008), a critical step in
our protocol for EB induction involves switching to media
with neural induction medium (NIM) the day after EB
formed, to promote neuronal differentiation. Given the
beneficial role of Sonic Hedgehog (SHH) signaling in the
control of dorsal midbrain development (Martinez et al.,
2013), we added SHH to the DA expansion medium to
govern the formation of DA neurons.
ROS are a double-edged sword in biological systems, as
they can be either beneficial to living systems during
oxygen-dependent reactions and aerobic respiration or
harmful if overproduced (Sena and Chandel, 2012). We
demonstrated that ROS levels were increased during
hiPSC-derived DA neuron differentiation and maturation,
suggesting that increased ROS levels serve as an important
stimulus associated with neuronal development. Accord-
ingly, mitochondrial membrane potential, as an indicator
of mitochondrial function, also increased over time. In
addition, increased ROS levels and membrane potential
were in line with increases in key enzyme activity associ-
ated with the respiratory chains, including complex I and
IV activity, and ATP levels. Thus, mitochondrial function
is enhanced during the course of DAneuron differentiationfromhiPSCs. As by-products of oxidative phosphorylation,
the production of large amounts of ATP through the mito-
chondrial electron transport chain is associated with ROS
generation and accumulation. Similarly, ATP and ROS
levels were increased in differentiated cells from hESCs
after 14 days of differentiation (Cho et al., 2006). The
increased levels of ROS were accompanied by upregulation
of ATP levels.
Consistent with results showing increased mitochon-
drial function, mitochondrial morphology and distribu-
tion were altered during differentiation. Mitochondrial
density was increased significantly both in neuronal pro-
cesses and the whole cell. Mitochondria become elon-
gated during the maturation of cells differentiated from
hESCs and hiPSCs (Cho et al., 2006; St John et al., 2005;
Varum et al., 2011). Furthermore, mitochondrial move-
ment and transport also increased during differentiation,
as shown by trends in mitochondrial travel distance,
velocity, and percentage of both retrograde and antero-
grade movable mitochondria. These results suggest
increased mitochondrial dynamics during DA neuronal
development.
The essential role of mitochondria in the differentiation
of DA neurons was further confirmed by application of
mitochondrial inhibitors/toxins to suppress respiratory
chain complexes IV and I from the NPCs stages. Treat-
ment with KCN or rotenone significantly inhibited the
differentiation and maturation of DA neurons along
with alterations in mitochondrial structure and function.
In addition, significantly lower levels of transcription fac-
tors in progenitor, immature, and mature DA neurons
were detected with KCN and rotenone treatments at
different differentiation stages, indicating that the poor
development of DA neurons induced by mitochondrial
malfunctions could also have resulted from interference
with the expression of transcription factors for DA neu-
rons. Interestingly, at the hiPSCs stage, application of
KCN and rotenone inhibited the formation of EBs and ro-
settes (Figure 2), which ultimately resulted in failure of in-
duction of DA neurons. These results further uncover the
importance of mitochondrial function in DA neuronal
development, not only in the maturation of NPCs and
immature DA neurons but also in the early stages before
NPC generation.
During differentiation, mitochondrial maturation re-
quires a dynamic network and a continuous balance be-
tween fission and fusion processes. The balance is main-
tained via quality control of mitochondrial fission and
fusion proteins. Drp1 (Yoon et al., 2003), a key mitochon-
dria protein controlling fission and biogenesis, has recently
been found to be indispensable in somatic cell reprogram-
ming to pluripotency (Vazquez-Martin et al., 2012) as well
as in differentiation of ESCs (Wang et al., 2014). However,Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016 689
further investigation is required to determine whether
Drp1 is involved in neurogenesis from iPSCs, and whether
the mitochondrial proteins controlling fusion events, such
as fusion proteins mitofusin 2 and optic atrophy 1 (Chen
et al., 2003), and mitochondrial trafficking regulator
Miro1 (mitochondrial rho GTPase 1) (Birsa et al., 2013),
key factors in normal embryonic development (Chen
et al., 2003; Yamaoka et al., 2011; Yoon et al., 2003),
are also involved in the differentiation and maturation
of iPSCs.
In summary, we have provided direct evidence of the
involvement of mitochondrial development in DA neuron
differentiation and maturation, and also provided a neuro-
physiologic model of mitochondrial development during
neurogenesis of DA neurons. We comprehensively evalu-
ated the properties of neuronal and mitochondrial struc-
ture and function during the course of formation and
maturation of human DA neurons derived from hiPSCs.
Our data clearly demonstrated the direct role of mitochon-
dria in DA neuronmaturation. The present model provides
an approach for the study of abnormal mitochondrial
structure, function, and dynamics in the pathogenesis of
neurodegenerative diseases such as PD.EXPERIMENTAL PROCEDURES
hiPSC Culture
BM2-3 hiPSCs from passages 16 to 20 were obtained from Dr. Su-
nita L. D’Souza. This BM2-3 iPSC line was derived from bone
marrow of a human subject clinically normal and verified by
fluorescent in situ hybridization test showing 46,XY. Cytogenetic
analysis of cultured human stem cells revealed a normal female
karyotype. This analysis does not show any evidence of a clinically
significant numerical or structural chromosome abnormality.
Cells were maintained under feeder-free conditions using Matrigel
(BD Biosciences)-coated 6-well tissue culture plates in Essential 8
Medium (E8, Life Technologies), supplemented with 10 mM
ROCK inhibitor Y27632 (Life Technologies) on passaging days.
Cells were routinely passaged as small clumps using a previously
described EDTA method (Beers et al., 2012).Formation of Embryoid Bodies and Induction of
Rosette
Feeder-free iPSCs were dissociated with TryplE and seeded onto
AggreWell800 plate (10,000 cells per EB; Stem Cell Technologies)
in E8 medium supplemented with 10 mM ROCK inhibitor
Y27632 for the first 24 hr; we changed 75% of the medium daily
with STEMdiff NIM (Stem Cell Technologies). EBs were harvested
after 5 days and plated onto poly-L-ornithine/laminin (PLO/L,
Sigma)-coated plates. One to two days after attachment, promi-
nent neural rosette structures were visible inside the attached neu-
ral aggregates. EBs were traced with ImageJ software. Rosettes were
formed by cells expressing proteins characteristic of progenitor
markers of PAX6 and Ki67.690 Stem Cell Reports j Vol. 7 j 678–692 j October 11, 2016Isolation of Stem/Progenitor Cells and Differentiation
of DA Neurons
We followed the differentiation protocol of Hartfield et al. (2014)
with some modifications. In brief, stem/progenitor cells from
neuronal rosette clusters were isolated using Neural Rosette Selec-
tion Reagent (Stem Cell Technologies) 5 days after incubation in
NIM. Detached cells were collected and plated onto PLO/L-coated
6-well plates for western blot analysis and complex activities mea-
surement (2 3 104 cells per well), 12-well plates for co-culture sys-
tem (1 3 104 cells per well), or coverslips for immunocytochem-
istry and electrophysiology (5 3 103 cells per coverslip). NPCs
were cultured in neural expansion medium (DMEM/F12 supple-
mentedwith 13 B27 andN2 [Life Technologies], fibroblast growth
factor 8a [100 ng/mL, Life Technologies], SHH C25II [200 ng/mL,
Life Technologies], heparin [2 mg/mL, Life Technologies], and 13
non-essential amino acids [Life Technologies]) for 5 days and
finally in DA neuronal differentiation medium (neurobasal me-
dium supplemented with L-glutamine [2 mM, Life Technologies],
13 B27 and N2 supplements, brain-derived neurotrophic factor
[25 ng/mL], glial-derived neurotrophic factor [20 ng/mL], N6,29-
O-dibutyryladenosine 39,59-cyclic monophosphate sodium salt
[100 mM, Sigma], and ascorbic acid [200 mM, Sigma]) for 5, 10,
15, and 20 days before further analysis.
For investigating the effects of KCN and Rotenone on DA
neuronal induction or rosette formation, a final concentration of
500 nM KCN or 10 nM rotenone was added into the cultural me-
dium at 2 days after rosette induction (Figure 5A), or hiPSCs (Fig-
ure S2) and KCN and rotenone were added during each medium
change afterward.
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